DBV Technologies (DBVT) Current Deferred Revenue (2015 - 2019)
DBV Technologies (DBVT) posted quarterly Current Deferred Revenue of $6.2 million for Q2 2019, up 25.46% on a QoQ basis from $5.0 million in Q4 2018.
DBV Technologies (DBVT) Current Deferred Revenue (2015 - 2019) Analysis & Trends
DBV Technologies (DBVT) has reported Current Deferred Revenue for 5 consecutive years, with $6.2 million the latest figure, recorded in Q2 2019.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $6.2 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $6.2 million (changed N/A YoY) and the FY2018 annual result came in at $5.0 million, up 23.26% from the prior year.
- Current Deferred Revenue climbed to $6.2 million in Q2 2019 per DBVT's latest filing, from $5.0 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for DBVT reached as high as $6.2 million in Q2 2019 and fell as low as $1.1 million in Q4 2015.
- A 5-year average of $4.2 million and a median of $4.7 million in 2016 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2016 — Current Deferred Revenue surged 310.62% — and 2017, when it decreased 14.13%.
- Year by year, Current Deferred Revenue stood at $1.1 million in 2015, then jumped by 310.62% to $4.7 million in 2016, then fell by 14.13% to $4.0 million in 2017, then increased by 23.26% to $5.0 million in 2018, then gained by 25.46% to $6.2 million in 2019.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $6.2 million, $5.0 million, and $4.0 million for Q2 2019, Q4 2018, and Q4 2017 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 6.22 Mn |
| Dec 31, 2018 | 4.96 Mn |
| Dec 31, 2017 | 4.03 Mn |
| Dec 31, 2016 | 4.69 Mn |
| Dec 31, 2015 | 1.14 Mn |